Results 1 to 10 of about 106,553 (247)

Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans. [PDF]

PLoS ONE, 2014
Very little is known about the growth and mutation rates of Mycobacterium tuberculosis during latent infection in humans. However, studies in rhesus macaques have suggested that latent infections have mutation rates that are higher than that observed ...
Roberto Colangeli, Vic L Arcus, Ray T Cursons, Ali Ruthe, Noel Karalus, Kathy Coley, Shannon D Manning, Soyeon Kim, Emily Marchiano, David Alland   +9 more
doaj   +45 more sources

Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. [PDF]

PLoS ONE, 2013
OBJECTIVE: To identify the incidence of and risk factors for tuberculosis in people living with HIV (PLHIV). DESIGN: Observational, prospective cohort study. METHODS: A total of 2069 HIV-infected patients was observed between July 2007 and December 2010.
Joanna d'Arc Lyra Batista, Maria de Fátima Pessoa Militão de Albuquerque, Magda Maruza, Ricardo Arraes de Alencar Ximenes, Marcela Lopes Santos, Ulisses Ramos Montarroyos, Demócrito de Barros Miranda-Filho, Heloisa Ramos Lacerda, Laura Cunha Rodrigues   +8 more
doaj   +5 more sources

Latent tuberculosis

Lung India, 2016
Ajaz Nabi Koul
doaj   +3 more sources

Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics

AJPM Focus, 2023
Introduction: Prevention of tuberculosis disease through diagnosis and treatment of latent tuberculosis infection is critical for achieving tuberculosis elimination in the U.S.
Laura A. Vonnahme, MPH, Julia Raykin, PhD, Matthew Jones, MS, Jee Oakley, MPH, Jon Puro, MPA, Adam Langer, DVM, Kaylynn Aiona, MPH, Robert Belknap, MD, Tracy Ayers, PhD, Jonathan Todd, PhD, Kathryn Winglee, PhD   +10 more
doaj   +1 more source

Latent Tuberculosis Infection in Potential Renal Transplant Recipients and Live Donors in a Tertiary Level Transplant Center in Nepal

Journal of Nobel Medical College, 2022
Background: Active tuberculosis in transplant recipients can result from latent infection with Mycobacterium Tuberculosis in the transplant recipients, donor tissue, or de novo post-transplant infection.
Suresh Maharjan, Bikash Khatri, Deepa Chemjong, Bijay Khatri, Dibya Singh Shah   +4 more
doaj   +1 more source

Interferon-gamma assay and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease: a summarization study

Egyptian Journal of Chest Disease and Tuberculosis, 2021
Background Latent tuberculosis is an important clinical problem. This problem might be significant in some specific groups of patients. The screening for latent tuberculosis is recommended for management of those patients at risk.
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
doaj   +1 more source

Determination of Urinary Neopterin/Creatinine Ratio to Distinguish Active Tuberculosis from Latent Mycobacterium tuberculosis Infection. [PDF]

, 2016
BACKGROUND: Biomarkers to distinguish latent from active Mycobacterium (M.) tuberculosis infection in clinical practice are lacking. The urinary neopterin/creatinine ratio can quantify the systemic interferon-gamma effect in patients with M. tuberculosis
Eisenhut, M, Hargreaves, DS, Housley, D, Mulla, R, Scott, A, Walters, A   +5 more
core   +7 more sources

Acceptance and influencing factors of preventive treatment for latent tuberculosis infection: a review

Zhongguo gonggong weisheng, 2023
Preventive treatment for latent tuberculosis infection is one of the key measures to achieve the goal of ending tuberculosis. Currently, the acceptance of preventive treatment among different populations is unclear.
Yemin YUAN, Shixue LI, Chengchao ZHOU
doaj   +1 more source

A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis

Frontiers in Chemistry, 2020
Tuberculosis is one of the deadliest infectious diseases worldwide and the prevalence of latent tuberculosis acts as a huge roadblock in the global effort to eradicate tuberculosis.
Ushashi Banerjee, Santhosh Sankar, Amit Singh, Nagasuma Chandra, Nagasuma Chandra   +4 more
doaj   +1 more source

Tuberculosis latente [PDF]

Revista chilena de enfermedades respiratorias, 2012
La tuberculosis continúa siendo un problema enorme en salud pública. Se ha estimado que anualmente en todo el mundo 9 millones de personas contraen esta enfermedad y que 2 millones de muertes se deben a la tuberculosis. La exposición al M. tuberculosis causa la enfermedad en cerca del 10% de la población expuesta. En el 90% restante de los expuestos la
openaire   +4 more sources